Associate Sponsors

Couch Health

2021 Lead Sponsor


2021 Executive Sponsors

Origins Insights

2021 Associate Sponsors

Be The Partner
COUCH Health

2021 Supporting Sponsors

Rare Patient Voice

Supporting Partner


About Patients as Partners EU

Patients as Partners EU is the first European event dedicated to:

The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need to involve patients in every aspect of R&D, including decentralized trials which can also support diverse representation.

What Attendees Walked Away With:

  • A range of examples of patient engagement ideas in the early stages of research to advance clinical outcomes
  • An understanding of how to design hybrid trials around patient preferences to drive better enrollment and retention
  • How to increase diversity in clinical trials
  • How to manage the issues that arise when implementing new approaches
  • How to influence organizational change to support patient engagement and clinical research awareness strategies
  • Expand your professional network by connecting with peers who can provide a wide range of insights
  • Learn directly from patient advocates who bring a broad spectrum of ideas to the conversations


Key Topics for 2021:

  • Decentralized Clinical Trials: Learnings from the Pandemic and What’s Next to Support Patients and Investigators? A Multi-stakeholder Perspective
  • The Patient View on Designing Hybrid Decentralized Trials
  • R&D Efforts to Bring Diverse Representation in Clinical Research 
  • Addressing the Reality of Underrepresented Communities in Clinical Research: Joint Perspectives
  • Scaling a Patient Engagement Training Program Co-Created by Pharma and Patients
  • A Joint Pharma-Patient Initiative on How Best to Incorporate the Patient Voice in the Pre-Clinical Phase
  • Understanding the Challenges Faced by Carers and Implementing Strategies in Support of Them
  • How Pharma Adapted to Support Patient Groups During Covid-19 to Continue to Engage Patients 

Why Now?

As more pharma and biotechs implement aspects of decentralized clinical trials due to the pandemic, more patients are able to get access to clinical research. For 2021, Patients as Partners Europe reported on the outcome and learnings of decentralized trials and how they are benefiting patients, how to close the gaps of vast underrepresentation, how pharma is supporting patient groups during Covid-19, how to include the patient voice in the pre-clinical phase, and understanding the challenges faced by carers.

It is our job to provide you with the best virtual conference experience. We presented Patients as Partners US in August to a global audience with a warm interactive exchange of peer-to-peer learning with the most patient representation and look forward to building on that for January 25-26, 2021. Let us know if you have any questions. 


Join the conversation early and become part of the Patients as Partners EU community by following us on LinkedIn and by following the conference hashtag #PatientsEU2021. If you are interested in participating in the Patients as Partners EU 2021 program, please contact us at Thank you.  



Mark Scherzer
Conference Producer

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Strategic Partnerships

Allyson Adams
Senior Marketing Manager

Adam Kolanko
Strategic Partnership Manager

Elizabeth Bard
Senior Strategic Partnership Manager


Meg Gould
Senior Conference Planner



  • "It was wonderful to have the opportunity to share with the audience our story and my role as one supporting an individual with what at times can be a very debilitating condition."

    - Al and Grace Samuels, Prostate Cancer Survivor & Caregiver

  • "Huge congratulations to the whole team for a great event. Thank you for being so welcoming, and for not just giving lip service to patient involvement but really living it out. Looking forward to next year already! "

    - Natasha Ratcliffe, Parkinsons's UK

  • "Overall really enjoyed the 2 days and connecting back with the reasons why industry exists and re-opening people's eyes to the big honest challenges that aren't always comfortable to hear."

    - Louise Evans, Bannga Partners

  • "I enjoyed the fact that there was a higher representation from patient groups than other conferences and these groups were engaged in the dialogue."

    - Sherina Kuruvilla, Novo Nordisk

  • "The audience was well invited: patients, agencies, pharma industry (even within the industry several departments lie RA, MA, clinical researchers) ALL with patient focus. "

    - Theodora Weisz, Akcea Therapeutics